Iduronate-2-sulfatase — Drug Target

All drugs that target Iduronate-2-sulfatase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Enzyme replacement therapy

Phase 3 pipeline (1)

• JR-141 or Idursulfase · JCR Pharmaceuticals Co., Ltd. · Enzyme replacement therapy · Rare genetic disease / Lysosomal storage disorder
  JR-141 is a recombinant idursulfase enzyme that replaces deficient iduronate-2-sulfatase to break down glycosaminoglycans in Hunter syndrome.